Lijing Wang

Central South University

Papers

2

Total Citations

34

H-Index

2

About

Lijing Wang is a pioneering researcher at the intersection of thoracic oncology and autonomous robotics, whose work spans two seemingly disparate but equally impactful fields. In surgical oncology, Wang has made transformative contributions to the treatment of stage III non-small cell lung cancer (NSCLC), a notoriously heterogeneous disease with poor prognosis. Their landmark 2022 prospective cohort study on robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy has garnered 24 citations, establishing a new paradigm for minimally invasive management of advanced lung cancer. This work demonstrates the feasibility and safety of combining cutting-edge immunotherapy with robotic precision, offering renewed hope for patients with limited treatment options. Simultaneously, Wang has advanced underwater robotics through their foundational 2016 study on path planning for unmanned underwater vehicles (UUVs) in dynamic environments. With 10 citations, this research addresses critical challenges in autonomous navigation, enabling optimal trajectory generation despite intermittent underwater conditions. Wang’s unique ability to bridge surgical innovation and robotics engineering positions them as a versatile scholar whose work has practical implications for both human health and oceanic exploration. Their dual expertise exemplifies how cross-disciplinary thinking can solve complex real-world problems.

Research Focus

Key Achievements

2
H-Index
2
Papers
34
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study
24 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Central South University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago